NPHC - HOLDS PATENTED SOLUTION TO THE OPIOID CRISIS NYLOXIN IS AWAITING DISTRIBUTION ON THE FSS AND GSA ADVANTAGE
The compilation of all these posts will help bring you up to speed To understand the process of getting NYLOXIN distributed to the government. Nyloxin is on the verge of completing the GSA listing process. Here is DD to support this belief
Thanks to BMOC91324 for calling Debra the CEO of EuroAmerican and posting this excellent DD: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139932525 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140061138 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140092902 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140034640 Nutra Pharma Partners with EuroAmerican IP to Distribute Nyloxin® for Sale to Government Agencies
PRESS RELEASE: https://globenewswire.com/news-release/2018/01/18/1296478/0/en/Nutra-Pharma-Partners-with-EuroAmerican-IP-to-Distribute-Nyloxin-for-Sale-to-Government-Agencies.html “We are excited to be working with Nutra Pharma,” commented Debra J Paul, CEO, and Tami Dana, COO, of EuroAmerican. “Nyloxin is an exciting alternative to opiate drugs. We believe that it can be a significant tool for combatting opioids in our veterans and in our military,” they continued. “We have seen that Nyloxin substantially reduces all types of pain without mental confusion, addiction or toxicity. We believe that we can quickly and successfully add the Nyloxin products to our existing product list for distribution through our Federal Supply Schedule #V797D-40251 to be available as a replacement for opioids and other pain management drugs” they concluded. EuroAmerican IP, LLC has been delivering Federal Supply Schedule Commodities to the BOP, DHS, DOJ, DOD, FBI, USCG, HHS, NIH, SSA, VA and other governmental agencies since 2009. Currently offering over 100 contracted items to VA's and OGA's. EAIP is proud to comment that we have only received excellent feedback and appreciation from loyal customers. Opioid abuse crisis takes heavy toll on US Veterans...
NPHC has a SOLUTION
November 10, 2017 NEW YORK –Opioid drug abuse has killed more Americans than the Iraq, Afghanistan and Vietnam wars combined, and U.S. veterans and advocates this Veteran's Day are focusing on how to help victims of the crisis. Veterans are twice as likely as non-veterans to die from accidental overdoses of the highly addictive painkillers, a rate that reflects high levels of chronic pain among vets, particularly those who served in the wars in Iraq and Afghanistan, according to federal data.
U.S. government and healthcare officials have been struggling to stem the epidemic of overdoses, which killed more than 64,000 Americans in the 12 months ending last January alone, a 21 percent increase over the previous year, according to the Centers for Disease Control. About 65,000 Americans died in Vietnam, Iraq and Afghanistan.
President Donald Trump named opioids a NATIONAL PUBLIC HEALTH EMERGENCY and a White House commission last week recommended establishing a nationwide system of drug courts and easier access to alternatives to opioids for people in pain.
"Our veterans deserve better than polished sound bites and empty promises," said former Democratic Congressman Patrick Kennedy, a recovering addict and a member of the president's opioid commission
THE TIME IS NOW...
IT IS A NATIONAL CRISIS...
NPHC HAS A REAL VIABLE SOLUTION!!!
AS WE SPEAK ITS IN THE PROCESS OF BECOMING DISTRIBUTED TO THE US GOVERNMENT!! Nutra Pharma Partners with NxGen Brands for Nyloxin® Distribution
PRESS RELEASE: https://www.nutrapharma.com/single-post/2018/04/19/Nutra-Pharma-Partners-with-NxGen-Brands-for-Nyloxin®-Distribution
“We are pleased to be working with NxGen Brands to expand the marketing of Nyloxin,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation
. “Over the past year, we have brought the Nyloxin product line back under our control and have updated our own websites. These efforts to increase internet awareness will continue as we join other marketing groups to greatly expand our reach to educate consumers about Nyloxin and get the product into the hands of those who need it most,” he continued. “We will also be working with NxGen Brands in our capacity as consultants to aid in expanding their in-house product line, improve their manufacturing and look for other synergies for combined growth,” he concluded.
OPENED UP ANOTHER DISTRIBUTION CHANNEL!
MARKETING NYLOXIN TO THE GENERAL POPULATION!
ANOTHER BUILDING BLOCK TO CREATING AWARENESS AND INCREASING SALES!! Nutra Pharma Announces Nyloxin® Distribution Agreement for Australia and New Zealand
PRESS RELEASE: https://globenewswire.com/news-release/2018/02/01/1330073/0/en/Nutra-Pharma-Announces-Nyloxin-Distribution-Agreement-for-Australia-and-New-Zealand.html
“We recently announced our domestic efforts to increase sales and distribution of Nyloxin," stated Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "This included the new website, web promotions and our application to be added to the Federal Supply Schedule for sales to US governmental agencies,” he continued. “I'm excited to announce that we have also been working to promote our products internationally. We have been moving forward with our efforts in Canada and India – and we are now announcing our agreement with Pharmachal to be our exclusive distributor of Nyloxin in Australia and New Zealand. Once they receive regulatory approval through the TGA, they will be able to warehouse, market and distribute Nyloxin throughout their territories. We believe this will allow for broad distribution and marketing in that region by the end of this year,” he concluded. NYLOXIN TO BE DISTRIBUTED AND MARKETED INTERNATIONALLY.
CANADA AND INDIA ARE NEXT... FACTS ABOUT NYLOXIN Non addictive pain solutions - OPIOID Alternative (FDA Registered)
* Amazon today
* NPHC Controls all patents
* Seeking Nyloxin distributors: Israel, South Africa, Canada, Central and South America
* Currently in 100 pharmacy's and doctors offices
* Working with Military and VA.
* Supported by Jack Brewer.(On Twitter) Executive Chairman & Portfolio Manager of The Brewer Group.
(Very successful investor/financier and has connections with Bio Tech) Nyloxin is all-natural, anti-inflammatory, analgesic pain relief that is non-toxic, non-narcotic, non-addictive, non-steroidal and does not contain aspirin or acetaminophen
"Nyloxin product is amazing. It’s non-addictive, no opiate, non-narcotic In the last model, it outperformed morphine. It lasted 4-6 hours longer than morphine without any of the side effects. Additionally, since the dose of Nyloxin is so small compared to the dose of morphine required, the Nyloxin was considered to be approximately 600 times more potent than the morphine on a molecular basis,” explained Rik Deitsch, CEO of Nutra Pharma Corp.
. "We have also stated that there are no contraindications in utilizing the Nyloxin with opiate drugs. In fact, since their mechanisms of action are so vastly different, we have seen a synergistic benefit. The recommendation is to continue the use of the opiate while introducing Nyloxin to the patient protocol. After a few weeks, most people can reduce their opiate use and many people have even eliminated their use of opiates over time in favor of the Nyloxin". He continued.
NYLOXIN IS A REVOLUTIONARY OPIOID SOLUTION IN MIDST OF A OPIOD REVOLUTION! ALL THE DD ABOVE demonstrates how there is more going on today than ever!!
NPHC was at 140 million dollar market cap just 3yrs ago with LESS THAN WE HAVE TODAY!!
Let that sink in......... NPHC is way UNDERVALUED here at 5Million dollar MC!
THE MARKET CAP CORRECTION IS COMING...